We observed a nonsignificant trend toward increased CD4/CD8 ratios in untreated RRMS patients, which was completely normalized within (but not below) physiological (HD) range in Dac-HYP cohort.
← all excerpts
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
2
—
—
The sentences
While similar trends were observed for LTi cells (enumerated in this study as c-kit+ ILCs), they did not reach statistical significance in the blood due to a single HD outlier.